NDC 0270-1410

Cystografin Dilute

Diatrizoate Meglumine

Cystografin Dilute is a Intravesical Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bracco Diagnostics Inc. The primary component is Diatrizoate Meglumine.

Product ID0270-1410_2ca3d703-43ee-8c20-fa77-109118c128e9
NDC0270-1410
Product TypeHuman Prescription Drug
Proprietary NameCystografin Dilute
Generic NameDiatrizoate Meglumine
Dosage FormInjection, Solution
Route of AdministrationINTRAVESICAL
Marketing Start Date1982-11-09
Marketing CategoryNDA / NDA
Application NumberNDA010040
Labeler NameBRACCO DIAGNOSTICS INC
Substance NameDIATRIZOATE MEGLUMINE
Active Ingredient Strength180 mg/mL
Pharm ClassesRadiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0270-1410-30

10 BOTTLE in 1 PACKAGE (0270-1410-30) > 300 mL in 1 BOTTLE
Marketing Start Date1982-11-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0270-1410-30 [00270141030]

Cystografin Dilute INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA010040
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1982-11-09

Drug Details

Active Ingredients

IngredientStrength
DIATRIZOATE MEGLUMINE180 mg/mL

OpenFDA Data

SPL SET ID:e56882fa-4a30-43b1-bb6b-f7d4a4101c4e
Manufacturer
UNII

Pharmacological Class

  • Radiographic Contrast Agent [EPC]
  • X-Ray Contrast Activity [MoA]
  • Radiographic Contrast Agent [EPC]
  • X-Ray Contrast Activity [MoA]

NDC Crossover Matching brand name "Cystografin Dilute" or generic name "Diatrizoate Meglumine"

NDCBrand NameGeneric Name
0270-1410Cystografin Dilutediatrizoate meglumine
0270-0149Cystografindiatrizoate meglumine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.